PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters
The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. The move is part of Lundbeck's ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data
A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth,  pointing ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's AI and robotics-driven drug discovery platform and its ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Basecamp Research raises $140M to advance AI-designed therapeutics
/C O R R E C T I O N -- Basecamp Research/ ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs
SHANGHAI and SHAOXING, China , Sept. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") and NovoCodex Biopharmaceuticals Co., Ltd. ("NovoCodex") jointly ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Windsor Capital Completes $50 Million Strategic Investment in Space Labs
Investment for a 4.9% minority stake implies an approximately $1 billion post-money valuation for the Slovenian technology company. ...
2026-09-24T    Auto   Banking/Financial Service   Biotechnology 
Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology
WILMINGTON, Del. , Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026
104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing ...
2026-09-23T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Angel Yeast's Angeopro™ Yeast Protein Achieves Dual International Certifications
Setting a New Standard in High-Quality Nutrition ...
2026-09-23T    Biotechnology   Chemical   Food/Beverages   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.